Zollinger-Ellison syndrome: Recent advances and controversies

Tetsuhide Ito, Hisato Igarashi, Robert T. Jensen

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Purpose of Review: To review the recent advances and current controversies in patients with Zollinger-Ellison syndrome (ZES). Recent Findings: Recent advances in the management of ZES include: improved understanding of the pathogenesis of gastrinoma and pancreatic neuroendocrine tumors, new prognostic classification systems, new diagnostic algorithms, more sensitive localization studies, new treatment strategies including improved control of gastric acid secretion and role for surgery, and new approaches to patients with advanced disease. Controversies include: the best approach to a patient with hypergastrinemia suspected of possibly having ZES, the appropriate gastrin assay to use, the role of surgery in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise order of therapeutic modalities in the treatment of patients with advanced disease. Summary: This review updates clinicians regarding important advances and controversies required to optimally diagnose and manage patients with ZES.

Original languageEnglish
Pages (from-to)650-661
Number of pages12
JournalCurrent Opinion in Gastroenterology
Volume29
Issue number6
DOIs
Publication statusPublished - Nov 1 2013

Fingerprint

Zollinger-Ellison Syndrome
Gastrinoma
Multiple Endocrine Neoplasia Type 1
Neuroendocrine Tumors
Gastric Acid
Gastrins
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Zollinger-Ellison syndrome : Recent advances and controversies. / Ito, Tetsuhide; Igarashi, Hisato; Jensen, Robert T.

In: Current Opinion in Gastroenterology, Vol. 29, No. 6, 01.11.2013, p. 650-661.

Research output: Contribution to journalReview article

Ito, Tetsuhide ; Igarashi, Hisato ; Jensen, Robert T. / Zollinger-Ellison syndrome : Recent advances and controversies. In: Current Opinion in Gastroenterology. 2013 ; Vol. 29, No. 6. pp. 650-661.
@article{20f0180ea8264977b3d7ea09140a4614,
title = "Zollinger-Ellison syndrome: Recent advances and controversies",
abstract = "Purpose of Review: To review the recent advances and current controversies in patients with Zollinger-Ellison syndrome (ZES). Recent Findings: Recent advances in the management of ZES include: improved understanding of the pathogenesis of gastrinoma and pancreatic neuroendocrine tumors, new prognostic classification systems, new diagnostic algorithms, more sensitive localization studies, new treatment strategies including improved control of gastric acid secretion and role for surgery, and new approaches to patients with advanced disease. Controversies include: the best approach to a patient with hypergastrinemia suspected of possibly having ZES, the appropriate gastrin assay to use, the role of surgery in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise order of therapeutic modalities in the treatment of patients with advanced disease. Summary: This review updates clinicians regarding important advances and controversies required to optimally diagnose and manage patients with ZES.",
author = "Tetsuhide Ito and Hisato Igarashi and Jensen, {Robert T.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1097/MOG.0b013e328365efb1",
language = "English",
volume = "29",
pages = "650--661",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Zollinger-Ellison syndrome

T2 - Recent advances and controversies

AU - Ito, Tetsuhide

AU - Igarashi, Hisato

AU - Jensen, Robert T.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Purpose of Review: To review the recent advances and current controversies in patients with Zollinger-Ellison syndrome (ZES). Recent Findings: Recent advances in the management of ZES include: improved understanding of the pathogenesis of gastrinoma and pancreatic neuroendocrine tumors, new prognostic classification systems, new diagnostic algorithms, more sensitive localization studies, new treatment strategies including improved control of gastric acid secretion and role for surgery, and new approaches to patients with advanced disease. Controversies include: the best approach to a patient with hypergastrinemia suspected of possibly having ZES, the appropriate gastrin assay to use, the role of surgery in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise order of therapeutic modalities in the treatment of patients with advanced disease. Summary: This review updates clinicians regarding important advances and controversies required to optimally diagnose and manage patients with ZES.

AB - Purpose of Review: To review the recent advances and current controversies in patients with Zollinger-Ellison syndrome (ZES). Recent Findings: Recent advances in the management of ZES include: improved understanding of the pathogenesis of gastrinoma and pancreatic neuroendocrine tumors, new prognostic classification systems, new diagnostic algorithms, more sensitive localization studies, new treatment strategies including improved control of gastric acid secretion and role for surgery, and new approaches to patients with advanced disease. Controversies include: the best approach to a patient with hypergastrinemia suspected of possibly having ZES, the appropriate gastrin assay to use, the role of surgery in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise order of therapeutic modalities in the treatment of patients with advanced disease. Summary: This review updates clinicians regarding important advances and controversies required to optimally diagnose and manage patients with ZES.

UR - http://www.scopus.com/inward/record.url?scp=84886091719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886091719&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e328365efb1

DO - 10.1097/MOG.0b013e328365efb1

M3 - Review article

C2 - 24100728

AN - SCOPUS:84886091719

VL - 29

SP - 650

EP - 661

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 6

ER -